Quant Focused Fund - Growth - Direct Plan

Other Plans and Options
  • (-1.4%)Nav, as on 18-01-2021

  • Previous Nav

  • Net Change on 18-01-2021

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary investment objective of the scheme is to seek to generate capital appreciation & provide longterm growth opportunities by investing in a focused portfolio of Large Cap – ‘blue chip’ – companies. There is no assurance that the investment objective of the Scheme will be realized.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Quant Focused Fund - Growth Option-Direct Plan 7.80 27.97 28.60 7.81 14.25 16.28
NIFTY 100 3.73 21.50 15.39 8.59 14.04 15.91

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Quant Focused Fund - Growth Option-Direct Plan Jan 07, 2013 28.60 7.81 14.25 0.57 7.70
Axis Focused 25 Fund - Direct Plan - Growth Option Jan 01, 2013 21.27 13.01 19.50 0.63 14,357.95
Franklin India Focused Equity Fund - Direct - Growth Jan 01, 2013 Unrated 16.59 7.01 14.86 0.95 7,465.95
Aditya Birla Sun Life Focused Equity Fund - Growth - Direct Plan Jan 01, 2013 18.21 9.12 14.77 1.09 4,643.53
Nippon India Focused Equity Fund - Direct Plan Growth Plan - Growth Option Jan 01, 2013 Unrated 22.09 4.37 13.95 1.39 4,447.91
DSP Focus Fund - Direct Plan - Growth Dec 31, 2012 Unrated 12.46 8.57 13.79 1.05 2,120.20

Fund Holdings as on 31-December-2020

  • Sun Pharmaceuticals Industries Ltd

  • Bharti Airtel Limited

  • Adani Ports & Special Economic Zone Ltd

  • Infosys Ltd.

  • Hindustan Unilever Ltd.

  • Dabur India Ltd

  • Tech Mahindra Limited

  • Stylam Industries Limited

  • HCL Technologies Ltd.

  • ICICI Lombard General Insurance Company Ltd.

  • Fortis Healthcare Ltd

  • Divis Laboratories Ltd.

  • Dr.Reddy Laboratories Ltd.

  • Cadila Healthcare Ltd

  • Torrent Pharmaceuticals Ltd

  • Biocon Ltd

  • Cipla Ltd.

  • TREPS

  • Nestle India Ltd.

  • NCA-NET CURRENT ASSETS

View More

  • Pharmaceuticals & Drugs

  • IT - Software

  • Household & Personal Products

  • Telecommunication - Service Provider

  • Port

  • Laminates/Decoratives

  • Insurance

  • Hospital & Healthcare Services

  • Miscellaneous

  • Consumer Food

View More

Fund Manager

  • Cash

  • Equity

View More

About Quant Focused Fund

NULL

Scheme Analysis

Quant Focused Fund is a Equity - Focused Fund fund and belongs to Quant Mutual Fund. It was launched on 07-Jan-2013 and currently has an AUM of ₹7.70 crore. Quant Focused Fund is benchmarked against NIFTY 100 as primary index.

The NAV of Quant Focused Fund ended down ₹-0.59(-1.4%)yesterday to ₹41.7098.

Among its top 3 holdings the fund has exposure to Sun Pharmaceuticals Industries Ltd, and

The Quant Focused Fund is managed by Sanjeev Sharma and Vasav Sahgal.

Fund House Contact

11, Scindia House, Connaught Circus, New Delhi - 110 001

011-43587415, 43587420
help@quant.in
011-43587432